X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (147) 147
amdinocillin pivoxil - therapeutic use (141) 141
female (110) 110
adult (96) 96
middle aged (80) 80
male (76) 76
urinary tract infections - drug therapy (72) 72
aged (56) 56
adolescent (53) 53
penicillanic acid - therapeutic use (51) 51
amdinocillin pivoxil - adverse effects (39) 39
amdinocillin pivoxil - administration & dosage (38) 38
urinary tract infections - microbiology (34) 34
amdinocillin - therapeutic use (33) 33
pivmecillinam (28) 28
infectious diseases (27) 27
clinical trials as topic (26) 26
pivampicillin - therapeutic use (26) 26
ampicillin - analogs & derivatives (24) 24
anti-bacterial agents - therapeutic use (23) 23
escherichia coli infections - drug therapy (23) 23
double-blind method (22) 22
acute disease (21) 21
bacteriuria - drug therapy (21) 21
index medicus (20) 20
microbial sensitivity tests (18) 18
random allocation (18) 18
trimethoprim - therapeutic use (18) 18
child (17) 17
microbiology (17) 17
pregnancy (17) 17
amdinocillin pivoxil - pharmacology (16) 16
child, preschool (15) 15
cystitis - drug therapy (15) 15
drug evaluation (15) 15
aged, 80 and over (14) 14
drug combinations - therapeutic use (14) 14
penicillins - therapeutic use (14) 14
pharmacology & pharmacy (14) 14
recurrence (14) 14
sulfamethoxazole - therapeutic use (13) 13
treatment outcome (13) 13
urinary tract infections (13) 13
administration, oral (12) 12
anti-infective agents, urinary - therapeutic use (12) 12
antibiotics (12) 12
bacterial infections - drug therapy (12) 12
drug combinations (12) 12
escherichia coli - drug effects (12) 12
penicillin resistance (12) 12
prospective studies (12) 12
pivampicillin - administration & dosage (11) 11
women (11) 11
drug therapy, combination (10) 10
dysentery, bacillary - drug therapy (10) 10
escherichia coli infections - microbiology (10) 10
mecillinam (10) 10
trimethoprim, sulfamethoxazole drug combination (10) 10
young adult (10) 10
amoxicillin - therapeutic use (9) 9
ampicillin - therapeutic use (9) 9
bacteriuria - microbiology (9) 9
cystitis - microbiology (9) 9
drug administration schedule (9) 9
infant (9) 9
pregnancy complications, infectious - drug therapy (9) 9
resistance (9) 9
urinary tract infection (9) 9
follow-up studies (8) 8
medicine, general & internal (8) 8
nitrofurantoin - therapeutic use (8) 8
time factors (8) 8
anti-infective agents - therapeutic use (7) 7
cystitis (7) 7
enterobacteriaceae infections - drug therapy (7) 7
escherichia coli - isolation & purification (7) 7
family practice (7) 7
feces - microbiology (7) 7
nalidixic acid - therapeutic use (7) 7
premedication (7) 7
staphylococcal infections - drug therapy (7) 7
sulfamethizole - therapeutic use (7) 7
urine - microbiology (7) 7
urogenital system (7) 7
anti-bacterial agents - pharmacology (6) 6
bacteria - drug effects (6) 6
bronchitis - drug therapy (6) 6
escherichia coli - enzymology (6) 6
escherichia-coli (6) 6
klebsiella infections - drug therapy (6) 6
pivampicillin - adverse effects (6) 6
pyelonephritis - drug therapy (6) 6
salmonella infections - drug therapy (6) 6
therapy (6) 6
trimethoprim (6) 6
urinary tract diseases (6) 6
ampicillin (5) 5
antimicrobial agents (5) 5
antimicrobial susceptibility (5) 5
bacteriuria (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (127) 127
Japanese (9) 9
Swedish (5) 5
Danish (4) 4
German (4) 4
French (2) 2
Norwegian (2) 2
Finnish (1) 1
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Infectious Diseases, ISSN 1471-2334, 11/2016, Volume 16, Issue 1, pp. 620 - 7
...)producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care... 
Urinary tract infection | Pivmecillinam | Extended-spectrum beta lactamase | Escherichia coli | Antibiotic resistance | Mean inhibitory concentration | INFECTIOUS DISEASES | RISK-FACTORS | ESCHERICHIA-COLI | DRUG-RESISTANCE | ANTIMICROBIAL RESISTANCE | MECILLINAM | CTX-M | TERM-CARE FACILITY | COMMUNITY | STAPHYLOCOCCUS-AUREUS | ENTEROBACTERIACEAE | Nursing Homes | Klebsiella pneumoniae - drug effects | Prevalence | Prospective Studies | Escherichia coli - drug effects | Humans | Drug Resistance, Bacterial | Male | Gram-Negative Bacteria - metabolism | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amdinocillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Ireland | Klebsiella pneumoniae - physiology | Escherichia coli - metabolism | General Practice | Amdinocillin - pharmacology | Female | Urinary Tract Infections - microbiology | Klebsiella pneumoniae - metabolism | beta-Lactamases - metabolism | Escherichia coli - physiology | Gram-Negative Bacteria - physiology | Escherichia coli Infections - drug therapy | Amdinocillin Pivoxil - therapeutic use | Klebsiella Infections - drug therapy | Risk Factors | Escherichia coli Infections - microbiology | Gram-Negative Bacterial Infections - drug therapy | Hospitalization | Amdinocillin Pivoxil - pharmacology | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Gram-Negative Bacteria - drug effects | Pilot Projects | Hospitals | Aged | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Care and treatment | Analysis | Urinary tract infections | Beta lactamases | Dosage and administration | Research | Health aspects | Infectious diseases
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 912 - 917
Journal Article
Médecine et maladies infectieuses, ISSN 0399-077X, 2012, Volume 42, Issue 2, pp. 66 - 75
Uncomplicated cystitis is one of the most frequent community infections. We report the French results of the international ARESC study on the clinical aspects,... 
Résistance aux antibiotiques | Uncomplicated cystitis | Cystite non compliquée | Escherichia coli | Antibiotic resistance | EUROPE | WOMEN | INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | PIVMECILLINAM | TRIMETHOPRIM | SUSCEPTIBILITY | PREVALENCE | PATHOGENS | Cystitis - urine | Prospective Studies | Humans | Middle Aged | Bacteriuria - microbiology | Bacteriuria - epidemiology | Enterobacteriaceae - isolation & purification | Cystitis - drug therapy | Young Adult | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcus saprophyticus - isolation & purification | Adult | Female | Staphylococcal Infections - microbiology | Amdinocillin Pivoxil - therapeutic use | France - epidemiology | Fosfomycin - therapeutic use | Fosfomycin - pharmacology | Enterobacteriaceae Infections - microbiology | Cystitis - microbiology | Europe - epidemiology | Amdinocillin Pivoxil - pharmacology | Drug Resistance, Microbial | Anti-Bacterial Agents - classification | Staphylococcal Infections - epidemiology | Nitrofurantoin - therapeutic use | Adolescent | Nitrofurantoin - pharmacology | Reproductive History | Aged | Anti-Bacterial Agents - pharmacology | Cystitis - epidemiology | Bacteriuria - drug therapy | Women | Drug resistance in microorganisms | Care and treatment | Health aspects | Cystitis
Journal Article
Journal Article
Journal of clinical microbiology, ISSN 0095-1137, 2006, Volume 44, Issue 5, pp. 1776 - 1781
Journal Article
Journal Article
Infectious Diseases, ISSN 2374-4235, 03/2016, Volume 48, Issue 3, pp. 241 - 245
Journal Article